Effect of FOLFOX chemotherapy on gene expression and on the FDG kinetics in a human colorectal cancer cell line

被引:0
|
作者
Dimitrakopoulou-Strauss, A
Strauss, LG
Koczan, D
Hoffend, J
Thiesen, HJ
Haberkorn, U
机构
[1] German Canc Res Ctr, Clin Cooperat Unit Nucl Med, D-6900 Heidelberg, Germany
[2] Univ Rostock, Inst Immunol, D-2500 Rostock 1, Germany
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:S287 / S287
页数:1
相关论文
共 50 条
  • [11] The efficiency of FOLFOX and XELOX application as a first-line chemotherapy of the advanced colorectal cancer patients
    Zeynalov, R.
    Musayev, I
    Gasanzadeh, J.
    Ahadova, N.
    Dadasheva, N.
    ANNALS OF ONCOLOGY, 2006, 17 : 81 - 81
  • [12] A phase II trial of modified FOLFOX as first-line chemotherapy in advanced colorectal cancer
    Xiong, Jian Ping
    Zhang, Ling
    Zhong, Lu Xing
    Qiu, Feng
    Xu, Jun
    Tao, Qing Song
    Xiang, Xiao Jun
    Yu, Feng
    Tang, Xiao Mei
    ANTI-CANCER DRUGS, 2007, 18 (09) : 1103 - 1107
  • [13] Stop and Go FOLFOX plus Bevacizumab Chemotherapy in the First-Line Treatment of Metastatic Colorectal Cancer
    Vaidyanathan, Gayatri
    Groman, Adrienne
    Wilding, Gregory
    Fakih, Marwan G.
    ONCOLOGY, 2010, 79 (1-2) : 67 - 71
  • [14] Neutropenia as a prognostic factor in metastatic colorectal cancer patients undergoing chemotherapy with first-line FOLFOX
    Shitara, K.
    Matsuo, K.
    Takahari, D.
    Yokota, T.
    Ura, T.
    Muro, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [15] Comparison of FDG kinetics and gene expression
    Strauss, LG
    Dimitrakopoulou-Strauss, A
    Klippel, A
    Koczan, D
    Haberkorn, U
    Schönleben, K
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S332 - S332
  • [16] Oxaliplatin,Fluorouracil and Leucovorin (FOLFOX) as First-line Chemotherapy for Metastatic or Recurrent Colorectal Cancer Patients
    Bing Han Ruihua Xu Yanxia Shi Huiyan Luo Xiaojuan Xiang Yuhong Li Li Zhang Tongyu Lin Youjian HeDepartment of Medical Oncology
    Chinese Journal of Clinical Oncology, 2007, (06) : 397 - 400
  • [17] Neutropaenia as a prognostic factor in metastatic colorectal cancer patients undergoing chemotherapy with first-line FOLFOX
    Shitara, Kohei
    Matsuo, Keitaro
    Takahari, Daisuke
    Yokota, Tomoya
    Inaba, Yoshitaka
    Yamaura, Hidekazu
    Sato, Yozo
    Najima, Mina
    Ura, Takashi
    Muro, Kei
    EUROPEAN JOURNAL OF CANCER, 2009, 45 (10) : 1757 - 1763
  • [18] In vitro modulation of CITED4 gene expression in a colorectal cancer cell line
    Rogers, M. A.
    Kalter, V.
    Marcias, G.
    Zapatka, M.
    Barbus, S.
    Radlwimmer, B.
    Lichter, P.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S69 - S70
  • [19] Popliteal pseudoaneurysm after FOLFOX chemotherapy for metastatic colorectal cancer
    Cosic, Luka
    Theivendren, Mayo
    Spanger, Manfred
    Weinberg, Laurence
    INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 2019, 63 : 1 - 4
  • [20] Influence of the DCC gene on proliferation and carcinoembryonic antigen expression in the human colorectal cancer cell line SW1116
    Jiang, H. W.
    Wang, J.
    Li, H. J.
    Peng, J. K.
    Gao, X. P.
    Chen, F.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (03) : 10273 - 10280